The scientific goal of the Developmental Cancer Therapeutics Program is to discover and characterize unique agents and pathways that will impact the development of more effective cancer therapies and to translate
these discoveries into clinical applications by using proof - of - principle, early phase clinical and correlative science studies.
IRDiRC Recognized Resources is a quality indicator, based on a specific set of criteria, that was created to highlight key resources which, if used more broadly, would accelerate the pace of translating
discoveries into clinical applications.
The efficient movement of basic science
discoveries into clinical applications — often described as «bench to bedside» work — is the goal of translational research.
Now, translational research has emerged as a field in its own right, aided in large part by the National Institutes of Health (NIH) Roadmap for Medical Research, a collection of initiatives that prioritize efforts to shepherd biomedical
discoveries into clinical application.
Yet, the fundamental insights into the mechanisms of metastasis will pave the way for the rationale translation of these preclinical
discoveries into clinical application.»
Not exact matches
During the webinar, our expert panel of researchers will discuss: • Strategies and technologies for successful cancer biomarker
discovery through robust detection and analysis of miRNAs in biofluids • Research
into analytic and biological variables that impact miRNA measurements in serum and plasma from the
clinical pathologist's point of view • The novel
application of miRNAs in serum as biomarkers of aging and chronic disease • The answers to questions submitted by the live, online viewers.
Translational research describes the process of translating scientific
discoveries into practical (
clinical)
applications.
While translational research has traditionally moved basic immunology knowledge forward
into clinical application, varying
clinical presentations of human immune - related disease processes, as well as variability in therapeutic outcomes, have provided opportunities for
discovery of novel mechanistic hypotheses directly from patients.
This label is a quality indicator, based on a specific set of criteria to highlight key resources, which, if used broadly, will accelerate the pace of translating
discoveries in rare diseases
into clinical applications.
As part of Sanford Health, the largest rural non-profit health care system in the nation, we can integrate research and patient care so that information flows seamlessly — translational genomic research
discoveries are accelerated
into clinical applications, such as new treatments and diagnostics to benefit patients, and
clinical data about patient response flows back to the labs to inform more
discoveries.
Scientific exploration at the Center for BrainHealth ® is leading edge, improving lives today and translating groundbreaking
discoveries into practical
clinical application.
Scientific exploration at the Center for BrainHealth ® is leading edge, improving lives today and translating groundbreaking
discoveries into practical
clinical application.
Scientific exploration at the Center for BrainHealth ® is leading edge, improving lives today and translating groundbreaking
discoveries into practical
clinical application.